Translating Inhaled and Nasal Technologies for the Delivery of Biologics

3/11/2020 12:25 - 13:00

  • Inhaled and nasal delivery has specific advantages as a delivery platform outside of its traditional use for asthma/COPD and seasonal rhinitis/sinusitis
  • Introduction to the advantages of inhaled and nasal targets for therapeutic biologics in a shifting landscape of drug delivery
  • Overview of current technologies available and successfully marketed products
  • Outline of the challenges, and solutions available, when formulating for these delivery routes

Please note that this will be a remote presentation

David Ward, Formulation and Manufacturing Lead, Intertek